- Motley Fool•10 hours ago
A Senate committee targets opioid drugmakers Purdue, Johnson & Johnson, Insys, Mylan, and Depomed.
- Investor's Business Daily•yesterday
DepoMed stock tumbled to a year-low Wednesday after the company pre-released negative first-quarter guidance.
Depomed Inc (NASDAQ: DEPO ) and activist investor Starboard Value reached an agreement which will see the drugmaker name a new CEO and add two new members to its board. Despite the latest developments, ...
DEPO : Summary for Depomed, Inc. - Yahoo Finance
Depomed, Inc. (DEPO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||12.89 x 100|
|Ask||13.68 x 400|
|Day's Range||12.74 - 13.90|
|52 Week Range||12.74 - 27.02|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-8.84|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|